These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30003636)

  • 1. Prophylactic recombinant thrombomodulin treatment prevents hepatic sinusoidal obstruction syndrome in high-risk pediatric patients that undergo hematopoietic stem cell transplants.
    Yamamoto S; Toyama D; Sugishita Y; Kaneko R; Okamoto N; Koganesawa M; Fujita S; Akiyama K; Matsuno R; Isoyama K
    Pediatr Transplant; 2018 Nov; 22(7):e13269. PubMed ID: 30003636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Effect of Recombinant Human Soluble Thrombomodulin for Hepatic Sinusoidal Obstruction Syndrome Model Mice.
    Kanou S; Miyashita T; Yamamoto Y; Takada S; Nakura M; Okazaki M; Ohbatake Y; Nakanuma S; Makino I; Tajima H; Takamura H; Fushida S; Ohta T
    In Vivo; 2020; 34(3):1037-1045. PubMed ID: 32354890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation.
    Park M; Park HJ; Eom HS; Kwon YJ; Park JA; Lim YJ; Yoon JH; Kong SY; Ghim TT; Lee HW; Yun T; Park BK
    Ann Transplant; 2013 Jan; 18():36-42. PubMed ID: 23792499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Recombinant Thrombomodulin for the Prophylaxis of Veno-Occlusive Complication in Allogeneiccit Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Kashyap R; Anwer F; Iqbal MA; Khalid F; Khan A; Ali MA; Anwar MY; Chaudhary A; Jaan A
    Hematol Oncol Stem Cell Ther; 2023 Jan; 16(2):93-101. PubMed ID: 34655527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
    Faraci M; Bertaina A; Luksch R; Calore E; Lanino E; Saglio F; Prete A; Menconi M; De Simone G; Tintori V; Cesaro S; Santarone S; Orofino MG; Locatelli F; Zecca M
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):313-320. PubMed ID: 30266674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prophylaxis of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome With Defibrotide After Hematopoietic Stem Cell Transplantation in Children: Single Center Experience.
    Karagun BS; Akbas T; Erbey F; Sasmaz İ; Antmen B
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e35-e39. PubMed ID: 34966102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1.
    Nakamura K; Hatano E; Miyagawa-Hayashino A; Okuno M; Koyama Y; Narita M; Seo S; Taura K; Uemoto S
    Liver Int; 2014 Nov; 34(10):1473-87. PubMed ID: 24498917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
    Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
    Richardson PG; Triplett BM; Ho VT; Chao N; Dignan FL; Maglio M; Mohty M
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):113-124. PubMed ID: 29301447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectral Doppler Ultrasound Can Help Diagnose Children With Hepatic Sinusoidal Obstructive Syndrome After Hematopoietic Stem Cell Transplantation.
    Thumar VD; Vallurupalli VM; Robinson AL; Staggs VS; Shah V; Dalal J; Chan SS
    Ultrasound Q; 2020 Mar; 36(1):6-14. PubMed ID: 30921102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation.
    Yakushijin K; Ikezoe T; Ohwada C; Kudo K; Okamura H; Goto H; Yabe H; Yasumoto A; Kuwabara H; Fujii S; Kagawa K; Ogata M; Onishi Y; Kohno A; Watamoto K; Uoshima N; Nakamura D; Ota S; Ueda Y; Oyake T; Koike K; Mizuno I; Iida H; Katayama Y; Ago H; Kato K; Okamura A; Kikuta A; Fukuda T
    Bone Marrow Transplant; 2019 May; 54(5):674-680. PubMed ID: 30127466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Thrombomodulin Attenuates Endothelial Cell Damage in Hepatic Sinusoidal Obstruction Syndrome.
    Takada S; Miyashita T; Yamamoto Y; Kanou S; Munesue S; Ohbatake Y; Nakanuma S; Okamoto K; Sakai S; Kinoshita J; Makino I; Nakamura K; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
    In Vivo; 2018; 32(6):1409-1417. PubMed ID: 30348695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.
    Corbacioglu S; Richardson PG
    Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
    Fujiwara H; Maeda Y; Sando Y; Nakamura M; Tani K; Ishikawa T; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanimoto M
    Transfusion; 2016 Apr; 56(4):886-92. PubMed ID: 26711692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous response to recombinant thrombomodulin by grade of sinusoidal obstructive syndrome after pediatric stem cell transplantation.
    Inagaki J; Kurauchi K; Fukano R; Noguchi M; Okamura J
    Bone Marrow Transplant; 2016 Nov; 51(11):1543-1545. PubMed ID: 27376445
    [No Abstract]   [Full Text] [Related]  

  • 18. Burden of illness associated with sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation.
    Cao Z; Villa KF; Lipkin CB; Robinson SB; Nejadnik B; Dvorak CC
    J Med Econ; 2017 Aug; 20(8):871-883. PubMed ID: 28562132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation.
    Seifert C; Wittig S; Arndt C; Gruhn B
    J Cancer Res Clin Oncol; 2015 May; 141(5):877-85. PubMed ID: 25335953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin.
    Stutz L; Halter JP; Heim D; Passweg JR; Medinger M
    Bone Marrow Transplant; 2022 Mar; 57(3):391-398. PubMed ID: 34980902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.